Cui, Qingbin

Qingbin Cui
Close

Positions

University of Toledo

Contact Info

Qingbin.Cui@UToledo.Edu

selected publications

Article (Faculty180)
- 2026
  
  Novel quinoxaline-based survivin degraders overcome docetaxel-resistance in castration-resistant prostate cancer. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy. 85:101356.
- 2026
  
  Targeting fatty acid synthase for cancer drug discovery: Retrospective analyses and outlook. Pharmacological reviews. 78:100105.
- 2026
  
  Targeting fatty acid synthase to overcome PARP inhibitor resistance and to create an artificial synthetic lethality for triple-negative breast cancer. Genes & diseases. 13:101817.
- 2025
  
  Design, synthesis, and evaluation of quinoxaline-based survivin inhibitors for castration-resistant prostate cancer. Bioorganic chemistry. 163:108714.
- 2025
  
  Gold complex QB1561 suppresses drug-resistant cancer cells by inhibiting TrxR and mitochondrial respiratory function. Frontiers in pharmacology. 16:1560880.
- 2025
  
  Investigation of the anticancer efficacy and impact on energy metabolism of dual-core gold(i) complex BGC2a. RSC medicinal chemistry.
Review (Faculty180)
- 2023
  
  Small Molecule Inhibitors Targeting the "Undruggable" Survivin: The Past, Present, and Future from a Medicinal Chemist's Perspective

full name

Qingbin Cui

visualizations

Cumulative publications in Scholars@UToledo

Co-author Network